Skip to main content
Growth HormoneVerified

IGF-1 DES

DES(1-3)IGF-1 · des(1-3)IGF-I

A truncated form of insulin-like growth factor 1 missing the first three N-terminal amino acids, a change that lowers its affinity for the IGF binding proteins that normally hold the full-length hormone. Characterised in laboratory studies. Not approved for human use.

IGF-1 DES
Category
Growth Hormone
Half-life
Not established in a public source
Common vial
Varies
Regulatory
Research only

Tracking and educational reference only, on values you enter or import yourself. Not medical advice or a dosing recommendation.

01

Regulatory status

Research only

This substance is sold and handled as a research material and is not approved for human use. There is no approved label, which means there is no agency-reviewed information about how it should be handled, who should avoid it, or what happens alongside other medicines.

Not approved for human use

A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.

02

Half-life

Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.

03

Storage & handling

No approved label defines handling.

04

References

  • Int J Biochem Cell Biol 1996: des(1-3)IGF-I, a truncated form of insulin-like growth factor-I

Read the source

Common questions

IGF-1 DES, answered plainly.

01What is IGF-1 DES?+

A truncated form of insulin-like growth factor 1 missing the first three N-terminal amino acids, a change that lowers its affinity for the IGF binding proteins that normally hold the full-length hormone. Characterised in laboratory studies. Not approved for human use. It is also referred to as DES(1-3)IGF-1, des(1-3)IGF-I. It is listed here under Growth Hormone as educational reference, which is not a recommendation to use it.

02Is IGF-1 DES FDA approved?+

Research only. This substance is sold and handled as a research material and is not approved for human use. There is no approved label, which means there is no agency-reviewed information about how it should be handled, who should avoid it, or what happens alongside other medicines.

03What is the half-life of IGF-1 DES?+

Not established in a public source. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.

04How is IGF-1 DES stored and handled?+

No approved label defines handling. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.

Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.